ArticleInvestigational new drugs2018

Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.

Songlin Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.